|

Teplizumab Clinical Trials

6 actively recruiting trials across 4 locations

▲ +1 trial since August 2026

Also known as: SAR446681, TZIELD

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

  • Sanofi5
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Indications

  • Diabetes6
  • Type 1 Diabetes Mellitus3
  • Type 1 Diabetes3

Other2 trials

Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes
Phase 2
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

Scottsdale, Arizona1 trial

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Scottsdale Clinical Trials- Site Number : 8400044

Phase 3

San Francisco, California1 trial

A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

Investigational Site

Aurora, Colorado1 trial

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

Barbara Davis Center

Phase 2

Atlanta, Georgia1 trial

Long-Term Outcomes of Teplizumab in Routine Clinical Care

Investigational Site Number: 8400003

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.